| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |